Figure 2.
CSF-1R inhibition monotherapy in stroke. (A) Previous studies on brain pre-conditioning reported the absence of microglial cells within the first days post ischemia (acute phase) worsened disease outcomes, including increased brain injury, peripheral infiltration and pro-inflammatory signaling, ultimately leading to aggravated neurodeficits. (B) Long-term treatment reveals the existence of an Iba-1+ (microglia/macrophages) cell population resistant to CSF-1R inhibition while global expression of inflammation-related markers was decreased. Long-term CSF-1R inhibition starting right after surgery led to aggravated motor functions, partly explained by homeostatic imbalance and impaired infarct reperfusion (88). Created with Biorender.com.